Sargramostim
Showing 1 - 25 of 501
Parkinson's Disease and Parkinsonism Trial in Omaha (Sargramostim)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Sargramostim
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Dec 22, 2022
Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma Trial in Boston (Sargramostim (GM-CSF), Pembrolizumab
Recruiting
- Unresectable Melanoma
- +3 more
- Sargramostim (GM-CSF)
- Pembrolizumab (anti-PD-1)
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
Down Syndrome Trial in Aurora (Sargramostim for Injection, Saline Placebo)
Not yet recruiting
- Down Syndrome
- Sargramostim for Injection
- Saline Placebo
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 28, 2022
Alzheimer Trial in Aurora (Sargramostim, Saline - comparator)
Recruiting
- Alzheimer Disease
- Sargramostim
- Saline - placebo comparator
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 19, 2022
Drug Kinetics, Drug Effects on Physiology Trial in Mount-Royal (sargramostim)
Recruiting
- Drug Kinetics
- Drug Effects on Physiology
- sargramostim
-
Mount-Royal, Quebec, CanadaAltaSciences
May 23, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +4 more
- Aerosol Sargramostim
- +5 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 30, 2023
COVID-19 Trial in Japan (Sargramostim, Placebo)
Completed
- COVID-19
- Sargramostim
- Placebo
-
Narita City, Chiba, Japan
- +6 more
Nov 1, 2021
Diffuse, Large B-Cell, Lymphoma Trial in Los Angeles (Rituximab)
Completed
- Diffuse, Large B-Cell, Lymphoma
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 15, 2021
Autoimmune Pulmonary Alveolar Proteinosis Trial in Los Altos, Cincinnati (Sargramostim)
Completed
- Autoimmune Pulmonary Alveolar Proteinosis
- Sargramostim
-
Los Altos, California
- +1 more
Aug 2, 2021
COVID-19, SARS-CoV-2 Trial in United States (Sargramostim, Standard of care)
Completed
- COVID-19
- SARS-CoV-2
- Sargramostim
- Standard of care
-
Fullerton, California
- +10 more
Feb 16, 2022
Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)
Recruiting
- Transplant-Related Hematologic Malignancy
- Sargramostim
- Control Arm
-
Atlanta, GeorgiaNorthside Hospital
Apr 4, 2022
COVID-19 Trial in Belgium (Sargramostim, Control)
Completed
- COVID-19
- Sargramostim
- Control
-
Brugge, Belgium
- +3 more
Mar 1, 2021
Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in Aurora (cryotherapy, sargramostim)
Completed
- Recurrent Prostate Cancer
- +3 more
- cryotherapy
- sargramostim
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Feb 8, 2022
Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)
Completed
- Head and Neck Cancer
- +3 more
- sargramostim
- oral salt and soda mouthwash
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 9, 2021
HER2-positive Breast Cancer, Stage III Ovarian Epithelial Cancer, Stage III Ovarian Germ Cell Tumor Trial in Seattle
Active, not recruiting
- HER2-positive Breast Cancer
- +8 more
- pNGVL3-hICD vaccine
- +6 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Oct 26, 2021
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in New
Active, not recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +4 more
- Falimarev
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 4, 2022
Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)
Recruiting
- Neuroblastoma Recurrent
- Natural killer cell
- +4 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Feb 22, 2023
Solid Tumor Trial in New Haven (sargramostim, topotecan HCl)
Completed
- Unspecified Adult Solid Tumor, Protocol Specific
- sargramostim
- topotecan hydrochloride
-
New Haven, ConnecticutYale Comprehensive Cancer Center
Aug 13, 2020
Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)
Recruiting
- Metastatic Cancer
- Keytruda Injectable Product
- +4 more
-
Rochester, MichiganAscension Providence Rochester Hospital
Jun 15, 2022
Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +3 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Transitional Cell Carcinoma Trial in New York (TICEĀ®-strain BCG, NY-ESO-1 protein, sargramostim)
Completed
- Transitional Cell Carcinoma
- TICEĀ®-strain BCG
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 8, 2021
Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)
Not yet recruiting
- Relapsed Neuroblastoma
- Refractory Neuroblastoma
- Natural Killer Cells
- +4 more
- (no location specified)
Jan 11, 2022
Covid19, SARS-CoV Infection Trial in Argentina, United States (Sargramostim, Placebo)
Completed
- Covid19
- SARS-CoV Infection
- Sargramostim
- Placebo
-
Phoenix, Arizona
- +36 more
Feb 22, 2022
Neuroblastoma (NB) Trial in New York (Irinotecan, temozolomide, Hu3F8)
Active, not recruiting
- Neuroblastoma (NB)
- Irinotecan
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 19, 2021
Lymphoma, Non-Hodgkin, HIV Trial in Los Angeles (Bleomycin sulfate, Vincristine sulfate, Doxorubicin HCl)
Completed
- Lymphoma, Non-Hodgkin
- HIV Infections
- Bleomycin sulfate
- +8 more
-
Los Angeles, CaliforniaUSC CRS
Oct 26, 2021